secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001213900-24-100971
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionomics enters $2M ATM offering with H.C. Wainwright, replaces prior $11.5M program
--------------------------------------------------------------------------------

- Signed ATM agreement with H.C. Wainwright for up to $2 million in ADSs; 3.0% sales commission.
- Prior $11.5M ATM program with Cantor Fitzgerald terminated before signing new agreement.
- Shelf registration on Form S-3 filed Nov 18, 2024 (File No. 333-283306) for the offering.
- Sales agent may sell ADSs on Nasdaq at market prices; no minimum required sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024100971/0001213900-24-100971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024100971/ea0221911-8k_bionom.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-100971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer